ArticleBMC gastroenterology2024

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study.

Horng-Yih Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.